373 related articles for article (PubMed ID: 23219871)
1. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
[TBL] [Abstract][Full Text] [Related]
2. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
[TBL] [Abstract][Full Text] [Related]
3. Depot-specific characteristics of adipose tissue-derived stromal cells in thyroid-associated orbitopathy.
Wong JSC; Chu WK; Li BF; Pang CP; Chong KK
Br J Ophthalmol; 2018 Aug; 102(8):1173-1178. PubMed ID: 29666119
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
Kumar S; Coenen M; Iyer S; Bahn RS
Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis.
Verma R; Choi D; Chen AJ; Harrington CA; Wilson DJ; Grossniklaus HE; Dailey RA; Ng J; Steele EA; Planck SR; Korn BS; Kikkawa D; Czyz CN; Foster JA; Kazim M; Harris GJ; Edward DP; Al-Hussain H; Maktabi AMY; Alabiad C; Garcia A; Rosenbaum JT
Br J Ophthalmol; 2022 Jul; 106(7):1012-1017. PubMed ID: 33637620
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
[TBL] [Abstract][Full Text] [Related]
7. [Mevastatin inhibits the differentiation of thyroid-associated ophthalmopathy derived orbital preadipocytes].
Yi W; Xu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):511-7. PubMed ID: 20543477
[TBL] [Abstract][Full Text] [Related]
8. [Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy].
Yi WS; Xu XL
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):156-61. PubMed ID: 21426847
[TBL] [Abstract][Full Text] [Related]
9. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
[TBL] [Abstract][Full Text] [Related]
10. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
Kumar S; Nadeem S; Stan MN; Coenen M; Bahn RS
J Mol Endocrinol; 2011 Jun; 46(3):155-63. PubMed ID: 21321093
[TBL] [Abstract][Full Text] [Related]
11. Culture and differentiation of human orbital preadipocytes in thyroid-associated ophthalmopathy.
Wang L; Wu Z; Yan J; Yang H; Chen Z
Yan Ke Xue Bao; 2005 Mar; 21(1):27-30, 37. PubMed ID: 17162913
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.
Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M
J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
Tong BD; Xiao MY; Zeng JX; Xiong W
Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
[TBL] [Abstract][Full Text] [Related]
15. [Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy].
Chen XL; He WM; Li W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 48(5):727-731. PubMed ID: 29130665
[TBL] [Abstract][Full Text] [Related]
16. Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy.
Song D; Wang R; Zhong Y; Li W; Li H; Dong F
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):433-40. PubMed ID: 22159761
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes.
Kong CS; Kim JA; Eom TK; Kim SK
J Nutr Biochem; 2010 May; 21(5):438-43. PubMed ID: 19427183
[TBL] [Abstract][Full Text] [Related]
18. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
Kumar S; Coenen MJ; Scherer PE; Bahn RS
J Clin Endocrinol Metab; 2004 Feb; 89(2):930-5. PubMed ID: 14764816
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
20. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Mulder MT; Hirankarn N; van Hagen PM; Dik WA
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5457-64. PubMed ID: 26284551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]